CurrentCardio coverage · page 13 of 15
European Journal of Heart Failure
Latest from European Journal of Heart Failure
Eur J Heart Fail
Early Changes in Estimated Glomerular Filtration Rate Post-Initiation of Empagliflozin in EMPEROR-Preserved
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Independent Prognostic Importance of Blood Urea Nitrogen to Creatinine Ratio in Heart Failure
Meta-analysisHeart failure
Eur J Heart Fail
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A Clinical Consensus Statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Guideline or statementValvular & structural
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Effects of Empagliflozin on Collagen Biomarkers in Patients with Heart Failure: Findings from the EMPEROR Trials
Secondary analysisHeart failure
Eur J Heart Fail
Impact of Vasodilators on Diuretic Response in Patients with Congestive Heart Failure: A Mechanistic Trial of Cimlanod (BMS-986231)
Randomised controlled trialHeart failure
Eur J Heart Fail
Eur J Heart Fail
European Society of Cardiology Core Curriculum for Cardio-Oncology
Guideline or statementCardio-oncology & other
Eur J Heart Fail
Eur J Heart Fail
Albuminuria in Transthyretin Cardiac Amyloidosis: Prevalence, Progression and Prognostic Importance
Cohort studyHeart failure
Eur J Heart Fail
Proteomic Prediction of Incident Heart Failure and Its Main Subtypes
Cohort studyHeart failure
Eur J Heart Fail
Eur J Heart Fail
Biatrial Myopathy in Heart Failure with Preserved Ejection Fraction
Cohort studyHeart failure
Eur J Heart Fail
Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial
Secondary analysisHeart failure
Eur J Heart Fail
Rationale and Design of the ESC Heart Failure III Registry – Implementation and Discovery
Trial designHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Clinical Presentation, Shock Severity and Mortality in Patients with De Novo Versus Acute-on-Chronic Heart Failure-Related Cardiogenic Shock
Cohort studyAcute care & resuscitation
Eur J Heart Fail
Growth Differentiation Factor-15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Comprehensive Vasodilatation in Women with Acute Heart Failure: Novel Insights from the GALACTIC Randomized Controlled Trial
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Clinical Characteristics and Prognosis of Patients with Isolated Cardiac Sarcoidosis: Insights from the ILLUMINATE-CS Study
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Phenotype, Outcomes and Natural History of Early-Stage Non-Ischaemic Cardiomyopathy
Cohort studyHeart failure
Eur J Heart Fail